1. Home
  2. KSCP vs RANI Comparison

KSCP vs RANI Comparison

Compare KSCP & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$4.82

Market Cap

57.7M

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.35

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
RANI
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.7M
134.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
KSCP
RANI
Price
$4.82
$1.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$8.67
AVG Volume (30 Days)
365.4K
2.6M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,610,000.00
$1,200,000.00
Revenue This Year
$8.68
$414.59
Revenue Next Year
$32.17
$30.15
P/E Ratio
N/A
N/A
Revenue Growth
5.50
N/A
52 Week Low
$2.45
$0.39
52 Week High
$17.79
$3.87

Technical Indicators

Market Signals
Indicator
KSCP
RANI
Relative Strength Index (RSI) 48.35 40.73
Support Level $4.35 $1.52
Resistance Level $5.06 $1.67
Average True Range (ATR) 0.33 0.13
MACD 0.04 -0.04
Stochastic Oscillator 43.16 3.04

Price Performance

Historical Comparison
KSCP
RANI

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: